TIMD4 and neoplasm: TIMD4 on tumour‐associated macrophages (TAMs) can mediate the degradation of apoptotic tumour cells, thereby enhancing the reactivity of APCs and CTLs, ultimately weakening the efficacy of anti‐tumour chemotherapy [32].